Interferon alfa-2a (recombinant)

Interferon alfa-2a (recombinant)
Trade Name Roferon-A
Orphan Indication Renal cancer
USA Market Approval USA
USA Designation Date 1988-04-18 00:00:00
Sponsor Hoffmann-La Roche, Inc.;340 Kingsland Street;Nutley, New Jersey, 07110